Ferumoxytol triggers cancer ferroptosis via an NF-κB-driven IRONKILL mechanismOA
Traditional radiotherapy and chemotherapy,despite killing tumor cells,often lack selectivity and therefore cause substantial collateral damage in patients1.Moreover,the ability of some cancer cells to evade these treatments may lead to relapse and metastasis2.Since 2012,ferroptosis has been a revolutionary approach in cancer therapy.Ferroptosis is driven by an abnormal accumulation of intracellular iron ions,which catalyze the buildup of lipid peroxides and ultimately disrupt cellular integrity3.This mechanism challenges conventional paradigms and offers a new strategy to combat refractory tumors that are resistant to apoptosis and prone to drug resistance.Because ferroptosis is triggered by iron-dependent lipid peroxidation(lipROS),a key question is how to selectively increase iron levels in tumor cells4.
Tao Luo;Meng Li;Shijie Zhang;Kang Ding;Feng Gu;Qinguo Huang
Nanjing Hospital of Chinese Medicine,Nanjing University of Chinese Medicine,Nanjing 210000,ChinaNanjing Hospital of Chinese Medicine,Nanjing University of Chinese Medicine,Nanjing 210000,ChinaNanjing Hospital of Chinese Medicine,Nanjing University of Chinese Medicine,Nanjing 210000,ChinaNanjing Hospital of Chinese Medicine,Nanjing University of Chinese Medicine,Nanjing 210000,ChinaDepartment of Laboratory Medicine,Xuzhou Central Hospital,Southeast University,Xuzhou 221000,ChinaDepartment of Neurosurgery,The Second Affiliated Hospital,Shantou University Medical College,Shantou 515000,China
医药卫生
ironkill mechanismintracellular iron ionswhichdisrupt cellular integritycancer ferroptosisradiotherapycancer cellsNF Bferumoxytol
《Cancer Biology & Medicine》 2026 (9)
P.1341-1345,5
supported by the National Natural Science Foundation of China(Grant No.82400186)the Natural Science Foundation of Jiangsu Province(Grant No.BK20240269)the Jiangsu Province Young Scientific and Technological Talents Promotion Program(Grant No.JSYJ-2025-728)the Feihong Program of Nanjing Hospital of Chinese Medicine(Grant No.FHJH202402)the Medical Scientific Research Foundation of Guang Dong Province(Grant No.A2023409)the Shantou Medical Health Science and Technology Plan(Grant No.220518116490852)the Guang Dong Basic and Applied Basic Research Foundation(Grant No.2026A1515012831).
评论